Consistent with our findings in human ovarian cancer cells, CCK-8 assays, EdU assays, and clonogenic assays in ID8 cells corroborated that SAA1 knockdown significantly inhibited proliferation and clonogenic capacity (Fig. S3C-G). Here, SAA1 is linked to ovarian carcinoma.